Genetic panel tests, such as those offered on Invitae’s metabolic/newborn screening test menu, provide an efficient, affordable option to help resolve these inconclusive cases.

SAN FRANCISCO, April 20, 2017 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced the addition of 80 new panels alongside ...

(2017-04-20 | NYSE:NVTA) Invitae announces expansion of its genetic test menu with addition of new tests and expanded panels for inherited metabolic and immune system disorders, including panels to ...